Jubilant Ingrevia Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 28, 2025, 12:01 am

Market Cap	11,918 Cr.
Current Price	750
High / Low	885/516
Stock P/E	47.4
Book Value	184
Dividend Yield	0.67 %
ROCE	11.1 %
ROE	8.87 %
Face Value	1.00
PEG Ratio	1.32

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Jubilant Ingrevia Ltd

Competitors of Jubilant Ingrevia Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
GRM Overseas Ltd	2,197 Cr.	366	376/176	43.1	65.3	0.00 %	12.0 %	14.6 %	2.00
Freshtrop Fruits Ltd	104 Cr.	130	175/105		141	0.00 %	6.12 %	5.36 %	10.0
Chamanlal Setia Exports Ltd	1,799 Cr.	348	447/203	17.5	142	0.64 %	16.8 %	14.2 %	2.00
Mangalam Global Enterprise Ltd	494 Cr.	15.0	17.0/10.1	19.9	6.12	0.07 %	16.6 %	14.6 %	1.00
LT Foods Ltd	16,781 Cr.	483	499/245	27.7	111	0.41 %	19.2 %	16.8 %	1.00
Industry Average	3,914.45 Cr	320.64		33.17	107.92	0.30%	12.27%	12.64%	3.50

All Competitor Stocks of Jubilant Ingrevia Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	1,296	1,166	1,304	1,158	1,145	1,075	1,020	966	1,074	1,024	1,045	1,057	1,051
Expenses	1,153	1,025	1,151	1,007	1,043	958	902	871	983	915	921	918	905
Operating Profit	142	141	153	151	102	117	118	96	91	110	124	138	147
OPM %	11%	12%	12%	13%	9%	11%	12%	10%	8%	11%	12%	13%	14%
Other Income	9	10	7	7	9	8	9	9	10	10	10	9	8
Interest	6	4	5	7	6	11	13	15	14	14	15	12	14
Depreciation	31	31	31	30	30	32	34	34	36	39	40	40	39
Profit before tax	115	116	124	122	76	81	80	55	51	66	80	96	102
Tax %	40%	31%	32%	25%	31%	29%	28%	30%	43%	26%	26%	27%	27%
Net Profit	69	79	84	92	52	58	57	39	29	49	59	69	74
EPS in Rs	4.31	4.98	5.29	5.75	3.28	3.62	3.61	2.42	1.84	3.06	3.70	4.36	4.65

Last Updated: May 31, 2025, 8:44 am

Below is a detailed analysis of the quarterly data for Jubilant Ingrevia Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 1,051.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,057.00 Cr. (Dec 2024) to 1,051.00 Cr., marking a decrease of 6.00 Cr..
For Expenses, as of Mar 2025, the value is 905.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 918.00 Cr. (Dec 2024) to 905.00 Cr., marking a decrease of 13.00 Cr..
For Operating Profit, as of Mar 2025, the value is 147.00 Cr.. The value appears strong and on an upward trend. It has increased from 138.00 Cr. (Dec 2024) to 147.00 Cr., marking an increase of 9.00 Cr..
For OPM %, as of Mar 2025, the value is 14.00%. The value appears strong and on an upward trend. It has increased from 13.00% (Dec 2024) to 14.00%, marking an increase of 1.00%.
For Other Income, as of Mar 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Dec 2024) to 8.00 Cr., marking a decrease of 1.00 Cr..
For Interest, as of Mar 2025, the value is 14.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.00 Cr. (Dec 2024) to 14.00 Cr., marking an increase of 2.00 Cr..
For Depreciation, as of Mar 2025, the value is 39.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 40.00 Cr. (Dec 2024) to 39.00 Cr., marking a decrease of 1.00 Cr..
For Profit before tax, as of Mar 2025, the value is 102.00 Cr.. The value appears strong and on an upward trend. It has increased from 96.00 Cr. (Dec 2024) to 102.00 Cr., marking an increase of 6.00 Cr..
For Tax %, as of Mar 2025, the value is 27.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 27.00%.
For Net Profit, as of Mar 2025, the value is 74.00 Cr.. The value appears strong and on an upward trend. It has increased from 69.00 Cr. (Dec 2024) to 74.00 Cr., marking an increase of 5.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 4.65. The value appears strong and on an upward trend. It has increased from 4.36 (Dec 2024) to 4.65, marking an increase of 0.29.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 6:12 am

Metric	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	0	684	4,949	4,773	4,136	4,178
Expenses	0	567	4,108	4,224	3,708	3,659
Operating Profit	-0	117	841	549	427	519
OPM %		17%	17%	11%	10%	12%
Other Income	0	-10	22	32	29	38
Interest	0	7	31	22	53	56
Depreciation	0	22	123	122	136	158
Profit before tax	-0	77	709	437	268	344
Tax %	0%	30%	33%	30%	32%	27%
Net Profit	-0	54	477	308	183	251
EPS in Rs	-3.40	3.41	29.93	19.31	11.48	15.77
Dividend Payout %	0%	10%	17%	26%	43%	31%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	783.33%	-35.43%	-40.58%	37.16%
Change in YoY Net Profit Growth (%)	0.00%	-818.76%	-5.15%	77.74%

Jubilant Ingrevia Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2021-2022 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	-5%
TTM:	1%

Compounded Profit Growth
10 Years:	%
5 Years:	331%
3 Years:	-20%
TTM:	34%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	17%
1 Year:	47%

Return on Equity
10 Years:	%
5 Years:	12%
3 Years:	9%
Last Year:	9%

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:52 am

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	0.05	16	16	16	16	16
Reserves	-0	1,907	2,417	2,650	2,722	2,911
Borrowings	0	556	238	407	740	764
Other Liabilities	0	888	1,111	1,176	1,241	1,341
Total Liabilities	0	3,366	3,782	4,249	4,719	5,032
Fixed Assets	0	1,805	1,798	1,846	2,539	2,581
CWIP	0	65	174	525	331	525
Investments	0	50	6	8	15	37
Other Assets	0	1,446	1,804	1,870	1,834	1,889
Total Assets	0	3,366	3,782	4,249	4,719	5,032

Below is a detailed analysis of the balance sheet data for Jubilant Ingrevia Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 16.00 Cr..
For Reserves, as of Mar 2025, the value is 2,911.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,722.00 Cr. (Mar 2024) to 2,911.00 Cr., marking an increase of 189.00 Cr..
For Borrowings, as of Mar 2025, the value is 764.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 740.00 Cr. (Mar 2024) to 764.00 Cr., marking an increase of 24.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 1,341.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,241.00 Cr. (Mar 2024) to 1,341.00 Cr., marking an increase of 100.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 5,032.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,719.00 Cr. (Mar 2024) to 5,032.00 Cr., marking an increase of 313.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 2,581.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,539.00 Cr. (Mar 2024) to 2,581.00 Cr., marking an increase of 42.00 Cr..
For CWIP, as of Mar 2025, the value is 525.00 Cr.. The value appears strong and on an upward trend. It has increased from 331.00 Cr. (Mar 2024) to 525.00 Cr., marking an increase of 194.00 Cr..
For Investments, as of Mar 2025, the value is 37.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2024) to 37.00 Cr., marking an increase of 22.00 Cr..
For Other Assets, as of Mar 2025, the value is 1,889.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,834.00 Cr. (Mar 2024) to 1,889.00 Cr., marking an increase of 55.00 Cr..
For Total Assets, as of Mar 2025, the value is 5,032.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,719.00 Cr. (Mar 2024) to 5,032.00 Cr., marking an increase of 313.00 Cr..

Notably, the Reserves (2,911.00 Cr.) exceed the Borrowings (764.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Month		Mar 2020	Mar 2021	Mar 2022	Mar 2023
Cash from Operating Activity +	0	112	453	462	430	508
Cash from Investing Activity +	0	33	-71	-469	-568	-393
Cash from Financing Activity +	0	-72	-418	42	144	-129
Net Cash Flow	0	73	-36	35	6	-13

Free Cash Flow

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	0.00	-439.00	603.00	142.00	-313.00	-245.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	251	43	39	50
Inventory Days	601	117	146	160
Days Payable	685	103	113	131
Cash Conversion Cycle	167	57	72	80
Working Capital Days	269	59	61	64
ROCE %	8%	29%	16%	10%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	51.10%	51.47%	51.47%	51.47%	51.47%	51.47%	51.47%	51.47%	51.47%	51.47%	51.47%	51.47%
FIIs	11.21%	10.19%	9.24%	8.40%	7.73%	6.15%	6.30%	6.35%	6.58%	6.55%	7.22%	6.89%
DIIs	0.67%	0.70%	2.36%	4.89%	5.97%	6.72%	9.18%	11.17%	13.60%	14.07%	15.47%	15.99%
Public	36.82%	37.44%	36.72%	35.03%	34.62%	34.83%	32.22%	30.17%	27.53%	27.10%	25.09%	24.90%
Others	0.20%	0.20%	0.20%	0.19%	0.19%	0.82%	0.82%	0.82%	0.81%	0.81%	0.77%	0.74%
No. of Shareholders	1,91,477	1,93,858	1,95,704	1,86,895	1,85,062	1,86,294	1,73,533	1,62,202	1,50,388	1,42,736	1,25,367	1,24,830

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
DSP Small Cap Fund	5,188,657	1.84	217.82	5,188,657	2025-04-22 15:56:56	0%
DSP Mid Cap Fund	3,926,722	1.14	164.84	3,926,722	2025-04-22 15:56:56	0%
Nippon India Small Cap Fund	1,156,299	0.13	48.54	1,156,299	2025-04-22 17:25:29	0%
DSP Top 100 Equity Fund	1,082,115	1.54	45.43	1,082,115	2025-04-22 15:56:56	0%
DSP Tiger Fund	877,161	1.49	36.82	877,161	2025-04-22 17:25:29	0%
DSP Equity Savings Fund	148,777	0.91	6.25	148,777	2025-04-22 17:25:29	0%
Nippon India Nifty Smallcap 250 Index Fund	44,284	0.26	1.86	44,284	2025-04-22 17:25:29	0%
Motilal Oswal Nifty Smallcap 250 Index Fund	27,802	0.26	1.17	27,802	2025-04-22 17:25:29	0%
DSP Regular Savings Fund	22,959	0.54	0.97	22,959	2025-04-22 17:25:29	0%
SBI Nifty Smallcap 250 Index Fund	20,406	0.26	0.86	20,406	2025-04-22 15:56:56	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	1.00	1.00	1.00	1.00	1.00
Basic EPS (Rs.)	11.56	19.34	29.98	20.78	-3.31
Diluted EPS (Rs.)	11.55	19.34	29.97	20.78	-3.31
Cash EPS (Rs.)	20.19	27.03	37.75	4.80	-3.32
Book Value[Excl.RevalReserv]/Share (Rs.)	173.27	167.72	153.06	120.73	-2.32
Book Value[Incl.RevalReserv]/Share (Rs.)	173.27	167.72	153.06	120.73	-2.32
Revenue From Operations / Share (Rs.)	261.78	300.23	311.34	42.95	0.00
PBDIT / Share (Rs.)	28.89	36.52	54.31	7.52	-3.32
PBIT / Share (Rs.)	20.27	28.83	46.55	6.13	-3.32
PBT / Share (Rs.)	16.94	27.47	44.60	4.86	-3.32
Net Profit / Share (Rs.)	11.57	19.35	29.99	3.41	-3.32
NP After MI And SOA / Share (Rs.)	11.58	19.34	29.99	3.41	-3.32
PBDIT Margin (%)	11.03	12.16	17.44	17.50	0.00
PBIT Margin (%)	7.74	9.60	14.95	14.27	0.00
PBT Margin (%)	6.47	9.15	14.32	11.31	0.00
Net Profit Margin (%)	4.42	6.44	9.63	7.94	0.00
NP After MI And SOA Margin (%)	4.42	6.44	9.63	7.94	0.00
Return on Networth / Equity (%)	6.68	11.53	19.59	2.82	0.00
Return on Capital Employeed (%)	9.29	14.88	26.96	3.93	143.10
Return On Assets (%)	3.86	7.22	12.55	1.60	-332.00
Long Term Debt / Equity (X)	0.15	0.05	0.04	0.23	0.00
Total Debt / Equity (X)	0.26	0.14	0.09	0.23	0.00
Asset Turnover Ratio (%)	0.92	1.16	1.38	0.41	0.00
Current Ratio (X)	1.38	1.54	1.68	1.59	0.30
Quick Ratio (X)	0.65	0.66	0.81	0.91	0.30
Inventory Turnover Ratio (X)	2.06	2.84	4.08	0.00	0.00
Dividend Payout Ratio (NP) (%)	43.18	25.84	9.52	0.00	0.00
Dividend Payout Ratio (CP) (%)	24.75	18.49	7.56	0.00	0.00
Earning Retention Ratio (%)	56.82	74.16	90.48	0.00	0.00
Cash Earning Retention Ratio (%)	75.25	81.51	92.44	0.00	0.00
Interest Coverage Ratio (X)	8.67	26.90	27.91	16.34	0.00
Interest Coverage Ratio (Post Tax) (X)	4.47	15.25	16.41	10.18	0.00
Enterprise Value (Cr.)	7789.81	6031.88	7331.49	4498.03	0.00
EV / Net Operating Revenue (X)	1.88	1.26	1.48	6.57	0.00
EV / EBITDA (X)	17.07	10.39	8.49	37.57	0.00
MarketCap / Net Operating Revenue (X)	1.73	1.20	1.44	6.08	0.00
Retention Ratios (%)	56.81	74.15	90.47	0.00	0.00
Price / BV (X)	2.61	2.15	2.94	2.16	0.00
Price / Net Operating Revenue (X)	1.73	1.20	1.44	6.08	0.00
EarningsYield	0.02	0.05	0.06	0.01	0.00

After reviewing the key financial ratios for Jubilant Ingrevia Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
For Basic EPS (Rs.), as of Mar 24, the value is 11.56. This value is within the healthy range. It has decreased from 19.34 (Mar 23) to 11.56, marking a decrease of 7.78.
For Diluted EPS (Rs.), as of Mar 24, the value is 11.55. This value is within the healthy range. It has decreased from 19.34 (Mar 23) to 11.55, marking a decrease of 7.79.
For Cash EPS (Rs.), as of Mar 24, the value is 20.19. This value is within the healthy range. It has decreased from 27.03 (Mar 23) to 20.19, marking a decrease of 6.84.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 173.27. It has increased from 167.72 (Mar 23) to 173.27, marking an increase of 5.55.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 173.27. It has increased from 167.72 (Mar 23) to 173.27, marking an increase of 5.55.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 261.78. It has decreased from 300.23 (Mar 23) to 261.78, marking a decrease of 38.45.
For PBDIT / Share (Rs.), as of Mar 24, the value is 28.89. This value is within the healthy range. It has decreased from 36.52 (Mar 23) to 28.89, marking a decrease of 7.63.
For PBIT / Share (Rs.), as of Mar 24, the value is 20.27. This value is within the healthy range. It has decreased from 28.83 (Mar 23) to 20.27, marking a decrease of 8.56.
For PBT / Share (Rs.), as of Mar 24, the value is 16.94. This value is within the healthy range. It has decreased from 27.47 (Mar 23) to 16.94, marking a decrease of 10.53.
For Net Profit / Share (Rs.), as of Mar 24, the value is 11.57. This value is within the healthy range. It has decreased from 19.35 (Mar 23) to 11.57, marking a decrease of 7.78.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 11.58. This value is within the healthy range. It has decreased from 19.34 (Mar 23) to 11.58, marking a decrease of 7.76.
For PBDIT Margin (%), as of Mar 24, the value is 11.03. This value is within the healthy range. It has decreased from 12.16 (Mar 23) to 11.03, marking a decrease of 1.13.
For PBIT Margin (%), as of Mar 24, the value is 7.74. This value is below the healthy minimum of 10. It has decreased from 9.60 (Mar 23) to 7.74, marking a decrease of 1.86.
For PBT Margin (%), as of Mar 24, the value is 6.47. This value is below the healthy minimum of 10. It has decreased from 9.15 (Mar 23) to 6.47, marking a decrease of 2.68.
For Net Profit Margin (%), as of Mar 24, the value is 4.42. This value is below the healthy minimum of 5. It has decreased from 6.44 (Mar 23) to 4.42, marking a decrease of 2.02.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 4.42. This value is below the healthy minimum of 8. It has decreased from 6.44 (Mar 23) to 4.42, marking a decrease of 2.02.
For Return on Networth / Equity (%), as of Mar 24, the value is 6.68. This value is below the healthy minimum of 15. It has decreased from 11.53 (Mar 23) to 6.68, marking a decrease of 4.85.
For Return on Capital Employeed (%), as of Mar 24, the value is 9.29. This value is below the healthy minimum of 10. It has decreased from 14.88 (Mar 23) to 9.29, marking a decrease of 5.59.
For Return On Assets (%), as of Mar 24, the value is 3.86. This value is below the healthy minimum of 5. It has decreased from 7.22 (Mar 23) to 3.86, marking a decrease of 3.36.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.15. This value is below the healthy minimum of 0.2. It has increased from 0.05 (Mar 23) to 0.15, marking an increase of 0.10.
For Total Debt / Equity (X), as of Mar 24, the value is 0.26. This value is within the healthy range. It has increased from 0.14 (Mar 23) to 0.26, marking an increase of 0.12.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.92. It has decreased from 1.16 (Mar 23) to 0.92, marking a decrease of 0.24.
For Current Ratio (X), as of Mar 24, the value is 1.38. This value is below the healthy minimum of 1.5. It has decreased from 1.54 (Mar 23) to 1.38, marking a decrease of 0.16.
For Quick Ratio (X), as of Mar 24, the value is 0.65. This value is below the healthy minimum of 1. It has decreased from 0.66 (Mar 23) to 0.65, marking a decrease of 0.01.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.06. This value is below the healthy minimum of 4. It has decreased from 2.84 (Mar 23) to 2.06, marking a decrease of 0.78.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 43.18. This value is within the healthy range. It has increased from 25.84 (Mar 23) to 43.18, marking an increase of 17.34.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 24.75. This value is within the healthy range. It has increased from 18.49 (Mar 23) to 24.75, marking an increase of 6.26.
For Earning Retention Ratio (%), as of Mar 24, the value is 56.82. This value is within the healthy range. It has decreased from 74.16 (Mar 23) to 56.82, marking a decrease of 17.34.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 75.25. This value exceeds the healthy maximum of 70. It has decreased from 81.51 (Mar 23) to 75.25, marking a decrease of 6.26.
For Interest Coverage Ratio (X), as of Mar 24, the value is 8.67. This value is within the healthy range. It has decreased from 26.90 (Mar 23) to 8.67, marking a decrease of 18.23.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 4.47. This value is within the healthy range. It has decreased from 15.25 (Mar 23) to 4.47, marking a decrease of 10.78.
For Enterprise Value (Cr.), as of Mar 24, the value is 7,789.81. It has increased from 6,031.88 (Mar 23) to 7,789.81, marking an increase of 1,757.93.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.88. This value is within the healthy range. It has increased from 1.26 (Mar 23) to 1.88, marking an increase of 0.62.
For EV / EBITDA (X), as of Mar 24, the value is 17.07. This value exceeds the healthy maximum of 15. It has increased from 10.39 (Mar 23) to 17.07, marking an increase of 6.68.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.73. This value is within the healthy range. It has increased from 1.20 (Mar 23) to 1.73, marking an increase of 0.53.
For Retention Ratios (%), as of Mar 24, the value is 56.81. This value is within the healthy range. It has decreased from 74.15 (Mar 23) to 56.81, marking a decrease of 17.34.
For Price / BV (X), as of Mar 24, the value is 2.61. This value is within the healthy range. It has increased from 2.15 (Mar 23) to 2.61, marking an increase of 0.46.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.73. This value is within the healthy range. It has increased from 1.20 (Mar 23) to 1.73, marking an increase of 0.53.
For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 23) to 0.02, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Jubilant Ingrevia Ltd as of June 30, 2025 is: 623.03

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 30, 2025, Jubilant Ingrevia Ltd is Overvalued by 16.93% compared to the current share price 750.00

Intrinsic Value of Jubilant Ingrevia Ltd as of June 30, 2025 is: 846.30

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 30, 2025, Jubilant Ingrevia Ltd is Undervalued by 12.84% compared to the current share price 750.00

Last 5 Year EPS CAGR: 35.84%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has higher reserves (2,101.17 cr) compared to borrowings (450.83 cr), indicating strong financial stability. The company has shown consistent growth in sales (116.67 cr) and profit (305.83 cr) over the years.	The stock has a low average ROCE of 12.60%, which may not be favorable. The stock has a high average Working Capital Days of 90.60, which may not be favorable. The stock has a high average Cash Conversion Cycle of 75.20, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Jubilant Ingrevia Ltd:
1. Net Profit Margin: 4.42%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 9.29% (Industry Average ROCE: 12.27%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 6.68% (Industry Average ROE: 12.64%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 4.47
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.65
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 47.4 (Industry average Stock P/E: 33.17)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.26
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Jubilant Ingrevia Ltd. is a Public Limited Listed company incorporated on 23/10/2019 and has its registered office in the State of Uttar Pradesh, India. Company's Corporate Identification Number(CIN) is L24299UP2019PLC122657 and registration number is 122657. Currently Company is involved in the business activities of Manufacture of basic chemicals. Company's Total Operating Revenue is Rs. 3941.23 Cr. and Equity Capital is Rs. 15.93 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Agricultural Products	Bhartiagram, Amroha District Uttar Pradesh 244223	investors.ingrevia@jubl.com http://www.jubilantingrevia.com

Management
Name	Position Held
Mr. Shyam S Bhartia	Chairman
Mr. Hari S Bhartia	Co-Chairman & WholeTime Director
Mr. Deepak Jain	Managing Director & CEO
Mr. Chandan Singh	Co-CEO & Whole Time Director
Mr. Priyavrat Bhartia	Director
Mr. Arjun Shanker Bhartia	Director
Ms. Sudha Pillai	Independent Director
Mr. Sushil Kumar Roongta	Independent Director
Mr. Arun Seth	Independent Director
Mr. Pradeep Banerjee	Independent Director
Mr. Siraj Azmat Chaudhry	Independent Director
Ms. Ameeta Chatterjee	Independent Director

FAQ

What is the intrinsic value of Jubilant Ingrevia Ltd?

Jubilant Ingrevia Ltd's intrinsic value (as of 30 June 2025) is 623.03 — 16.93% lower the current market price of 750.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 11,918 Cr. market cap, FY2025-2026 high/low of 885/516, reserves of 2,911 Cr, and liabilities of 5,032 Cr.

What is the Market Cap of Jubilant Ingrevia Ltd?

The Market Cap of Jubilant Ingrevia Ltd is 11,918 Cr..

What is the current Stock Price of Jubilant Ingrevia Ltd as on 30 June 2025?

The current stock price of Jubilant Ingrevia Ltd as on 30 June 2025 is 750.

What is the High / Low of Jubilant Ingrevia Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Jubilant Ingrevia Ltd stocks is ₹885/516.

What is the Stock P/E of Jubilant Ingrevia Ltd?

The Stock P/E of Jubilant Ingrevia Ltd is 47.4.

What is the Book Value of Jubilant Ingrevia Ltd?

The Book Value of Jubilant Ingrevia Ltd is 184.

What is the Dividend Yield of Jubilant Ingrevia Ltd?

The Dividend Yield of Jubilant Ingrevia Ltd is 0.67 %.

What is the ROCE of Jubilant Ingrevia Ltd?

The ROCE of Jubilant Ingrevia Ltd is 11.1 %.

What is the ROE of Jubilant Ingrevia Ltd?

The ROE of Jubilant Ingrevia Ltd is 8.87 %.

What is the Face Value of Jubilant Ingrevia Ltd?

The Face Value of Jubilant Ingrevia Ltd is 1.00.